Citation: Cb. Xue et al., Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1 ', a series of selective TNF-alpha converting enzyme inhibitorswith potent cellular activity in the inhibition of TNF-alpha release, J MED CHEM, 44(21), 2001, pp. 3351-3354
Authors:
Xue, CB
Voss, ME
Nelson, DJ
Duan, JJW
Cherney, RJ
Jacobson, IC
He, XH
Roderick, J
Chen, LH
Corbett, RL
Wang, L
Meyer, DT
Kennedy, K
DeGrado, WF
Hardman, KD
Teleha, CA
Jaffee, BD
Liu, RQ
Copeland, RA
Covington, MB
Christ, DD
Trzaskos, JM
Newton, RC
Magolda, RL
Wexler, RR
Decicco, CP
Citation: Cb. Xue et al., Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro andin vivo, J MED CHEM, 44(16), 2001, pp. 2636-2660
Citation: Rj. Cherney et al., Macrocyclic hydroxamate inhibitors of matrix metalloproteinases and TNF-alpha production, BIOORG MED, 9(9), 1999, pp. 1279-1284
Authors:
Xue, CB
Roderick, J
Mousa, S
Olson, RE
DeGrado, WF
Citation: Cb. Xue et al., Synthesis and antiplatelet effects of an isoxazole series of glycoprotein IIb/IIIa antagonists, BIOORG MED, 8(24), 1998, pp. 3499-3504